Ian N. Bruce
Oxford Road
Manchester, ENG, United Kingdom
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 247 publications
Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.
Journal: Zeitschrift fur Rheumatologie
Published: April 30, 2026
The SLICC/ACR damage index, assessed using a community-based electronic healthcare record, predicts mortality in SLE patients: results from the United Kingdom Clinical Practice Research Datalink.
Journal: Rheumatology advances in practice
Published: February 02, 2026
Refining Human Phenotype Ontology (HPO) to enable better phenotype-genotype integration in systemic autoimmune rheumatic diseases.
Journal: Orphanet journal of rare diseases
Published: January 26, 2026
Anifrolumab Plus Standard of Care Reduces Long-Term Cardiovascular Damage in Adults With Systemic Lupus Erythematosus: Findings From a Real-World External Control Study.
Journal: ACR open rheumatology
Published: December 15, 2025
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 31, 2025
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP-SC Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 31, 2025
Long-Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus Erythematosus.
Journal: ACR open rheumatology
Published: July 28, 2025
Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.
Journal: Journal of clinical epidemiology
Published: June 20, 2025
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 22, 2025
Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality.
Journal: Annals of the rheumatic diseases
Published: May 06, 2025
Noonan Syndrome Spectrum Disorders Predispose to Systemic Lupus Erythematosus: Case Report and Critical Review of the Literature.
Journal: American journal of medical genetics. Part A
Published: April 04, 2025
Dual B-cell targeting in systemic lupus erythematosus: The role of combined and sequential therapy with rituximab and belimumab.
Journal: Autoimmunity reviews
Published: March 28, 2025
Last Updated: 09/26/2026